GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » PS Ratio

Aptamer Group (LSE:APTA) PS Ratio : 0.67 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aptamer Group's share price is £0.008. Aptamer Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.01. Hence, Aptamer Group's PS Ratio for today is 0.67.

The historical rank and industry rank for Aptamer Group's PS Ratio or its related term are showing as below:

LSE:APTA' s PS Ratio Range Over the Past 10 Years
Min: 0.22   Med: 6.19   Max: 123.33
Current: 0.67

During the past 4 years, Aptamer Group's highest PS Ratio was 123.33. The lowest was 0.22. And the median was 6.19.

LSE:APTA's PS Ratio is ranked better than
96.1% of 999 companies
in the Biotechnology industry
Industry Median: 9.18 vs LSE:APTA: 0.67

Aptamer Group's Revenue per Sharefor the six months ended in Dec. 2023 was £0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.01.

During the past 12 months, the average Revenue per Share Growth Rate of Aptamer Group was -77.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 21.30% per year.

During the past 4 years, Aptamer Group's highest 3-Year average Revenue per Share Growth Rate was 21.30% per year. The lowest was 21.30% per year. And the median was 21.30% per year.

Back to Basics: PS Ratio


Aptamer Group PS Ratio Historical Data

The historical data trend for Aptamer Group's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group PS Ratio Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23
PS Ratio
- - 15.24 2.70

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23
PS Ratio Get a 7-Day Free Trial - 15.24 - 2.70 -

Competitive Comparison of Aptamer Group's PS Ratio

For the Biotechnology subindustry, Aptamer Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptamer Group's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's PS Ratio distribution charts can be found below:

* The bar in red indicates where Aptamer Group's PS Ratio falls into.



Aptamer Group PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Aptamer Group's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.008/0.012
=0.67

Aptamer Group's Share Price of today is £0.008.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptamer Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Aptamer Group  (LSE:APTA) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Aptamer Group PS Ratio Related Terms

Thank you for viewing the detailed overview of Aptamer Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptamer Group (LSE:APTA) Business Description

Traded in Other Exchanges
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines